+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are conducting a multicenter, prospective, randomized controlled trial to compare three types of haemostatic materialsHemocoll fibrillar Type-I collagen haemostat FTC, Avitene Microfibrillar Collagen Hemostat MCH, and conventional bone wax. The trial focuses on controlling bleeding from exposed cancellous bone in adults undergoing planned single-ray amputation involving phalangeal, metacarpal, or metatarsal bones. The main goal is to evaluate which material best achieves complete haemostasis at specific times after application, with Hemocoll FTC and Avitene MCH being directly compared primarily. Participants are randomly assigned to receive one of the three haemostatic materials applied directly to the exposed cancellous bone surface after the amputation, tourniquet release, and standardized soft-tissue haemostasis. A common compression method using sterile gauze and elastic crepe bandage is applied for 60 seconds across all groups. The primary haemostasis assessment times vary by anatomical site 2 minutes for phalanx, 3 minutes for metacarpal, and 5 minutes for metatarsal bones. Secondary comparisons include evaluating Hemocoll FTC versus bone wax and Avitene MCH versus bone wax. During the trial, participants will be monitored for haemostasis success, bleeding grades, time to haemostasis, and possible complications such as rebleeding or wound issues. Surgeons will also assess ease of application and material use. The study includes intraoperative assessments and follows participants for postoperative bleeding, hematoma, and adverse events related to the materials. The study plans to enroll 135 adults and expects to complete by January 2027.

Age: 18Years +All GendersPhase Not Applicable
3 locations